Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study

BACKGROUND: Preliminary analysis from the Vax-On study did not find a correlation between cancer treatment type and antibody response to COVID-19 vaccination. We carried out a secondary subgroup analysis to verify the effects of comprehensive cancer treatment classification on vaccine immunogenicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggeri, E.M., Nelli, F., Fabbri, A., Onorato, A., Giannarelli, D., Giron Berrios, J.R., Virtuoso, A., Marrucci, E., Mazzotta, M., Schirripa, M., Panichi, V., Pessina, G., Signorelli, C., Chilelli, M.G., Primi, F., Natoni, F., Fazio, S., Silvestri, M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626231/
https://www.ncbi.nlm.nih.gov/pubmed/34942438
http://dx.doi.org/10.1016/j.esmoop.2021.100350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626231/
https://www.ncbi.nlm.nih.gov/pubmed/34942438
http://dx.doi.org/10.1016/j.esmoop.2021.100350

Ejemplares similares